These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 17938952)
1. From the genome to the proteome--biomarkers in colorectal cancer. Habermann JK; Bader FG; Franke C; Zimmermann K; Gemoll T; Fritzsche B; Ried T; Auer G; Bruch HP; Roblick UJ Langenbecks Arch Surg; 2008 Jan; 393(1):93-104. PubMed ID: 17938952 [TBL] [Abstract][Full Text] [Related]
2. From genome to proteome in tumor profiling: molecular events in colorectal cancer genesis. Habermann JK; Roblick UJ; Upender M; Ried T; Auer G Adv Exp Med Biol; 2006; 587():161-77. PubMed ID: 17163165 [TBL] [Abstract][Full Text] [Related]
3. Proteomic strategies for the characterization and the early detection of lung cancer. Massion PP; Caprioli RM J Thorac Oncol; 2006 Nov; 1(9):1027-39. PubMed ID: 17409991 [TBL] [Abstract][Full Text] [Related]
4. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity. Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833 [TBL] [Abstract][Full Text] [Related]
5. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine. Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327 [TBL] [Abstract][Full Text] [Related]
6. Proteome analysis for the identification of tumor-associated biomarkers in gastrointestinal cancer. Fels LM; Buschmann T; Meuer J; Reymond MA; Lamer S; Röcken C; Ebert MP Dig Dis; 2003; 21(4):292-8. PubMed ID: 14752218 [TBL] [Abstract][Full Text] [Related]
7. Contributions of proteome profiling to the molecular analysis of cancer. Wang H; Hanash SM Technol Cancer Res Treat; 2002 Aug; 1(4):237-46. PubMed ID: 12625782 [TBL] [Abstract][Full Text] [Related]
8. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry. Liu XP; Shen J; Li ZF; Yan L; Gu J Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557 [TBL] [Abstract][Full Text] [Related]
9. Proteomics for discovery of candidate colorectal cancer biomarkers. Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574 [TBL] [Abstract][Full Text] [Related]
10. Detection of renal cell carcinoma-associated markers via proteome- and other 'ome'-based analyses. Seliger B; Lichtenfels R; Kellner R Brief Funct Genomic Proteomic; 2003 Oct; 2(3):194-212. PubMed ID: 15239923 [TBL] [Abstract][Full Text] [Related]
11. Contributions of advanced proteomics technologies to cancer diagnosis. Ciordia S; de Los Ríos V; Albar JP Clin Transl Oncol; 2006 Aug; 8(8):566-80. PubMed ID: 16952845 [TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer. Ma Y; Zhao M; Zhong J; Shi L; Luo Q; Liu J; Wang J; Yuan X; Huang C J Cell Biochem; 2010 Aug; 110(6):1512-9. PubMed ID: 20524204 [TBL] [Abstract][Full Text] [Related]
13. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Celis JE; Gromov P; Cabezón T; Moreira JM; Ambartsumian N; Sandelin K; Rank F; Gromova I Mol Cell Proteomics; 2004 Apr; 3(4):327-44. PubMed ID: 14754989 [TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer. Ma H; Chen G; Guo M Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366 [TBL] [Abstract][Full Text] [Related]
15. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627 [TBL] [Abstract][Full Text] [Related]
16. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease. Smith JG; Gerszten RE Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806 [TBL] [Abstract][Full Text] [Related]
17. Proteomic methodologies and their application in colorectal cancer research. Ikonomou G; Samiotaki M; Panayotou G Crit Rev Clin Lab Sci; 2009; 46(5-6):319-42. PubMed ID: 19958217 [TBL] [Abstract][Full Text] [Related]
18. Genomic and oncoproteomic advances in detection and treatment of colorectal cancer. McHugh SM; O'Donnell J; Gillen P World J Surg Oncol; 2009 Apr; 7():36. PubMed ID: 19338662 [TBL] [Abstract][Full Text] [Related]
19. Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarray. Matsubara J; Honda K; Ono M; Sekine S; Tanaka Y; Kobayashi M; Jung G; Sakuma T; Nakamori S; Sata N; Nagai H; Ioka T; Okusaka T; Kosuge T; Tsuchida A; Shimahara M; Yasunami Y; Chiba T; Yamada T Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2195-203. PubMed ID: 21828233 [TBL] [Abstract][Full Text] [Related]
20. Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Wulfkuhle JD; Paweletz CP; Steeg PS; Petricoin EF; Liotta L Adv Exp Med Biol; 2003; 532():59-68. PubMed ID: 12908550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]